381 |
Interleukin-1 signaling in the stressed CNS: From microglial source to neuronal destinationDiSabato, Damon J. January 2021 (has links)
No description available.
|
382 |
Role of P2X7 Receptors in Immune Responses During NeurodegenerationOliveira-Giacomelli, Ágatha, Petiz, Lyvia Lintzmaier, Andrejew, Roberta, Turrini, Natalia, Silva, Jean Bezerra, Sack, Ulrich, Ulrich, Henning 27 March 2023 (has links)
P2X7 receptors are ion-gated channels activated by ATP. Under pathological conditions,
the extensive release of ATP induces sustained P2X7 receptor activation, culminating
in induction of proinflammatory pathways with inflammasome assembly and cytokine
release. These inflammatory conditions, whether occurring peripherally or in the central
nervous system (CNS), increase blood-brain-barrier (BBB) permeability. Besides its well-known involvement in neurodegeneration and neuroinflammation, the P2X7 receptor
may induce BBB disruption and chemotaxis of peripheral immune cells to the CNS,
resulting in brain parenchyma infiltration. For instance, despite common effects on
cytokine release, P2X7 receptor signaling is also associated with metalloproteinase
secretion and activation, as well as migration and differentiation of T lymphocytes,
monocytes and dendritic cells. Here we highlight that peripheral immune cells mediate
the pathogenesis of Multiple Sclerosis and Parkinson’s and Alzheimer’s disease, mainly
through T lymphocyte, neutrophil and monocyte infiltration. We propose that P2X7
receptor activation contributes to neurodegenerative disease progression beyond its
known effects on the CNS. This review discusses how P2X7 receptor activation
mediates responses of peripheral immune cells within the inflamed CNS, as occurring
in the aforementioned diseases.
|
383 |
The Role of Neuroinflammation in the Pathogenesis of Amyotrophic Lateral SclerosisFrakes, Ashley E. January 2014 (has links)
No description available.
|
384 |
Cytokine expression, cytoskeleton organization, and viability of SIM-A9 microglia exposed to Staphylococcus aureus-derived lipoteichoic acid and peptidoglycanRoberts, Erin January 2017 (has links)
No description available.
|
385 |
HSV-1 Infection of C3H Central Nervous System Cell LinesVan Buren, Lauren Kay 27 September 2007 (has links)
No description available.
|
386 |
Alzheimer's disease pathology in aged chimpanzeesEdler, Melissa K. 26 July 2016 (has links)
No description available.
|
387 |
Studies on the role of Cofilin signaling in Hemin induced Microglial activationBin Sayeed, Muhammad Shahdaat 22 December 2016 (has links)
No description available.
|
388 |
Examination Of A Post-Stroke Drug Treatment For Its Effect On Blood Brain Barrier Permeability, And Gene Expression Changes In The Peri-Infarct RegionPatel, Ankita Anil 29 August 2016 (has links)
No description available.
|
389 |
Supraspinal Sensory Perception after Spinal Cord Injury and the Modulatory Factors Associated with Below-Level AllodyniaDetloff, Megan Ryan January 2009 (has links)
No description available.
|
390 |
Drivers of Immune Dysregulation in Late-onset Alzheimer's DiseaseRoy, Nainika January 2024 (has links)
The dysregulation of immune system function has been centrally implicated in numerous age-related and neurodegenerative disorders, including Alzheimer’s disease (AD). Genetic susceptibility studies have positioned microglia, brain-resident immune cells, as critical actors in the development and the progression of the disease.
Microglia are highly plastic cells with diverse functions across many modalities, and the appropriate regulation of their activities are a prerequisite for central nervous system homeostasis and cognitive health. Aging and pathogenic contexts are posited to modify microglial behavior, inhibiting their neuroprotective function and promoting a dysfunctional state that drives disease. However, the mechanisms underlying these pathogenic alterations in microglial state and function are complex and poorly understood.
This thesis identifies three elements that are altered in the AD brain and investigates how these mechanisms may serve as triggers producing microglial dysregulation in AD. Chapter 3 examines the role of expression of the transposable element LINE-1 in AD-related microglial dysfunction. Chapter 4 explores the regulation of PLCG2, which encodes a critical AD-associated signaling enzyme. Chapter 5 investigates the role of the AD-linked sorting receptor SORL1 in microglia. Together, these data expand our understanding of mechanisms driving altered microglial pathophysiology in AD and illuminate pathways of interest with potential therapeutic applications meriting deeper exploration.
|
Page generated in 0.1286 seconds